A hand reaching towards a digital interface, symbolizing on-demand access to Causal learning resources.

Implementing a Gold Standard FSP Strategic Partnership to Fuel Efficient Drug Development

1 minute read

Webinars

Published: March 7th, 2024

Complete the form below to watch the webinar

Featuring:

  • Francis Kendall, Head of Oncology Statistical Programming, Biometrics, Oncology R&D, AstraZeneca
  • Alan Salter, Director, R&D Clinical Partner Management, Takeda
  • Ping-Chung Chang, Head Business Transformation, Phastar
  • Elisa Mansfield, Vice President, FSP, Phastar

Moderated by Natalie Fforde, Senior Vice President, Global Strategic Partnerships, Phastar

Related articles

Regulatory Expectations: Bayesian Guidance from the FDA, CDE, and EMA
Webinars

Regulatory Expectations: Bayesian Guidance from the FDA, CDE, and EMA

July 21st, 2026 1 minute read

Bayesian methods are increasingly being considered to support dose optimization, extrapolation, and adaptive designs ...

AI for Clinical Research Series – Prediction
Webinars

AI for Clinical Research Series – Prediction

June 26th, 2026 1 minute read

Augmenting Clinical Trials with Synthetic or Simulated Patients, Projecting Long-Term Benefit-Risk, and Developing Re...

A Systematic Review into the Use of Bayesian Methods in Clinical Trials
Webinars

A Systematic Review into the Use of Bayesian Methods in Clinical Trials

June 25th, 2026 2 minute read

Bayesian methods continue to gain momentum as an alternative approach to traditional clinical trial design, yet many ...